Ads
related to: sickle cell diseasePatient Information · Clinical Trials Results · Prescribing Information · Find A Treatment Center
- Patient FAQs
Get Answers to Common Questions.
Understand the Potential Risks.
- Learn About Treatment
Learn About the Treatment Journey.
Watch the Video to Learn More.
- View Discussion Guides
Download Treatment Brochures,
Discussion Guides, and More.
- Safety and Side Effects
Review the Important Safety
Information & Side Effects.
- Patient FAQs
Search results
Results From The WOW.Com Content Network
Sickle cell test. A urologist might request this test for men with a higher risk of sickle cell disease. Duplex ultrasound. Sometimes called ultrasonography, this can measure blood flow in your ...
Clinical trials for one of the first attempts in somatic cell genome editing using CRISPR technology are for the treatment of sickle cell disease. he and his colleagues have published multiple peer-reviewed studies identifying gaps in knowledge of trial participants that could prevent them from giving adequately informed consent.
His description of the student's disease was known for many years as Herrick's syndrome, and is now known as sickle-cell disease. The condition is prevalent in West Africa . Herrick's second major contribution was a landmark article on myocardial infarction ("heart attack") in JAMA in 1912.
Common causes include asplenia (post-splenectomy) or congenital absence of spleen (right atrial appendage isomerism). Spleens are also removed for therapeutic purposes in conditions like hereditary spherocytosis, trauma to the spleen, and autosplenectomy caused by sickle cell anemia.
Autosplenectomy caused by sickle cell anemia or hyposplenism in coeliac disease [3] In patients with obstructive liver disease, lecithin cholesterol acetyltransferase activity is depressed, which increases the cholesterol-to-phospholipid ratio and produces an absolute increase in the surface area of the red cell membrane.
Tay–Sachs disease is a genetic disorder that results in the destruction of nerve cells in the brain and spinal cord. [1] The most common form is infantile Tay–Sachs disease, which becomes apparent around the age of three to six months of age, with the baby losing the ability to turn over, sit, or crawl. [1]